Antipsychotic Drugs
Download Antipsychotic Drugs full books in PDF, epub, and Kindle. Read online free Antipsychotic Drugs ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Alan F. Schatzberg |
Publisher | : American Psychiatric Pub |
Total Pages | : 838 |
Release | : 2019-03-25 |
Genre | : Medical |
ISBN | : 1615372601 |
Schatzberg's Manual of Clinical Psychopharmacology is a meticulously researched, yet down-to-earth guide for practitioners prescribing psychotropic medications to individuals with psychiatric disorders or symptoms mandating treatment. The ninth edition offers up-to-date information on current drugs, interactions, side effects, and dosing guidelines, and retains the strengths and features that have made it a standard text for trainees and practicing clinicians. The authors also include a new chapter on important developments in laboratory-guided pharmacotherapy, including pharmacogenomic testing, neurocognitive testing, quantitative EEG, and neuroimaging. Although the book's primary purpose is to provide the reader-practitioner with basic and practical information regarding the many classes of psychiatric medications, the authors stress that understanding how to select and prescribe psychotropic medications does not obviate the basic need to comprehensively evaluate and understand psychiatric patients. Accordingly, the book draws on the authors' clinical experience, as well as on the scientific literature, resulting in an accessible, yet rigorous text. Features that have helped cement this book's reputation include: Coverage is not limited to long-standing and newly approved medications, but also includes agents that are likely to receive approval from the FDA in the near future, ensuring that the reader stays up-to-date. References are provided for key statements, and each chapter is then followed by a list of selected relevant articles and books for readers who want to go beyond the material presented, making for a leaner, more reader-friendly guide. Dozens of summary tables with key information on classes of psychotropics function as quick-reference guides, promoting learning and serving as convenient resources for overloaded clinicians. The appendix offers two kinds of suggested readings. The first, for clinicians, is invaluable to trainees, while the second, for patients and families, helps point clinicians to books aimed at a lay audience to supplement information provided to patients. Staying abreast of both new medications and promising treatment protocols is essential in this rapidly evolving field. Schatzberg's Manual of Clinical Psychopharmacology delivers authoritative information in a friendly, collegial style, ensuring that both students and practicing clinicians are equipped to provide a superior standard of care.
Author | : Thomas L. Schwartz |
Publisher | : Nova Science Publishers |
Total Pages | : 0 |
Release | : 2013 |
Genre | : Antipsychotic drugs |
ISBN | : 9781621000716 |
Since the mid-1990s, a revolution in regards to prescribing antipsychotics has taken place. Once utilized only for schizophrenia, the newer, second generation antipsychotics have now been approved for the treatment of bipolar disorders, depressive disorders, and autism spectrum disorders. They are often utilised elsewhere for the treatment of anxiety disorders, sleep disorders, and to calm agitated patients when dangerous behaviours occur. Prescription rates have soared making them some of the most advertised, prescribed and profitable drugs on the market. This book was developed with input of international authors of varying backgrounds to review the history and development of these agents and to focus on the utilization of these drugs in various disorders, age groups, and clinical situations.
Author | : Thomas R.E. Barnes |
Publisher | : Academic Press |
Total Pages | : 304 |
Release | : 2013-10-22 |
Genre | : Medical |
ISBN | : 1483288102 |
In line with other volumes in the Neuroscience Perspectives Series, this volume covers the background, pharmacology, molecular biology, and biochemistry of antipsychotic drugs, together with an overview assessment of the therapeutic considerations. Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including motor side-effects like parkinsonism. Studies show that lowering doses may still produce the antipsychotic effect while lessening the risk of side-effects. As all available antispychotic drugs are able to block dopamine, specifically D2 receptors, doses below the threshold level for producing acute motor disorder can still be therapeutically effective. With the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with better side-effect potential has arisen. Other novel antipsychotic agents include D1 receptor blockers, partial dopamine agonists and non-dopamine drugs such as 5-HT receptor blockers, sigma receptor antagonists and NMDA receptor agonists. This volume reviews both the basic science of the conventional and atypical neuroleptics and their present and potential therapeutic use.
Author | : Anthony J. Rothschild |
Publisher | : American Psychiatric Pub |
Total Pages | : 395 |
Release | : 2010-01-12 |
Genre | : Medical |
ISBN | : 1585629294 |
The Evidence-Based Guide to Antipsychotic Medications is designed to provide both clinicians and residents with focused, comprehensive, and clinically relevant information regarding the use of antipsychotic medications to treat a broad range of psychiatric conditions -- from mood and anxiety disorders to substance abuse, personality disorders, and schizophrenia. The volume editor is a renowned psychiatrist and author with more than 25 years of experience in both clinical and research settings diagnosing and treating patients with mood and psychotic disorders. In addition, each of the volume's 13 contributors is an expert with many years of clinical experience to draw on.The book is down-to-earth and reader-friendly and is structured for maximal utility in both coverage and format: Key Clinical Points cap each chapter, synthesizing and summarizing the knowledge you can take away, and serving both as a refresher for those using the book as a reference and as a study aid to master the material. Both FDA-approved and off-label use of antipsychotic medications are addressed, reflecting the reality of clinical practice on the front lines. Use of antipsychotic medications in both the pediatric and geriatric populations, a potentially controversial subject, is addressed in a nonsensational, straight-forward manner. The Appendixes provide a wealth of information in tabular format, including drug tables (names, strengths, formulations, pharmacokinetics, and dosing); advice on initiating and monitoring antipsychotic medications; common side effects and their management; and special considerations for use during pregnancy and breastfeeding. The Evidence-Based Guide to Antipsychotic Medications is the first in a new series that strives to take evidence-based psychiatry from gold standard to standard practice. Scientifically up-to-date and rigorous, yet accessible and easy to understand, this volume stands alone as an indispensable resource on the topic.
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 80 |
Release | : 2009 |
Genre | : Medical |
ISBN | : 9241547693 |
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Author | : D. G. Cunningham Owens |
Publisher | : Cambridge University Press |
Total Pages | : 370 |
Release | : 1999-03-11 |
Genre | : Medical |
ISBN | : 9780521633536 |
A very readable and well illustrated 1999 clinical guide to the common side effects of antipsychotic medication.
Author | : J. Moncrieff |
Publisher | : Springer |
Total Pages | : 248 |
Release | : 2013-09-15 |
Genre | : Psychology |
ISBN | : 1137277440 |
A challenging reappraisal of the history of antipsychotics, revealing how they were transformed from neurological poisons into magical cures, their benefits exaggerated and their toxic effects minimized or ignored.
Author | : Katherine J. Aitchison |
Publisher | : CRC Press |
Total Pages | : 152 |
Release | : 1999-02-17 |
Genre | : Medical |
ISBN | : 9781853174353 |
The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management.
Author | : American Psychiatric Association |
Publisher | : American Psychiatric Pub |
Total Pages | : 220 |
Release | : 2016 |
Genre | : Medical |
ISBN | : 0890426775 |
The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms.
Author | : Jonathan M. Meyer |
Publisher | : Cambridge University Press |
Total Pages | : 403 |
Release | : 2021-09-02 |
Genre | : Medical |
ISBN | : 1009007513 |
Clinicians recognize that monitoring psychotropic levels provides invaluable information to optimize therapy and track treatment adherence, but they lack formal training specifically focused on the use of plasma antipsychotic levels for these purposes. As new technologies emerge to rapidly provide these results, the opportunity to integrate this information into clinical care will grow. This practical handbook clarifies confusing concepts in the literature on use of antipsychotic levels, providing clear explanations for the logic underlying clinically relevant concepts such as the therapeutic threshold and the point of futility, and how these apply to individual antipsychotics. It offers accessible information on the expected correlation between dosages and trough levels, and also provides a clear explanation of how to use antipsychotic levels for monitoring oral antipsychotic adherence, and methods to help clinicians differentiate between poor adherence and variations in drug metabolism. An essential resource for psychiatrists, psychiatric nurse practitioners, and mental health professionals worldwide.